Aerorxtx
AeroRx Therapeutics develops novel inhaled therapies specifically targeting Chronic Obstructive Pulmonary Disease (COPD). The company's pipeline focuses on combination drug products, including LABA/LAMA and LABA/LAMA/ICS formulations delivered via nebulization. This approach aims to provide improved treatment options for respiratory patients through advanced drug-device combination products.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- AeroRx Therapeutics develops novel inhaled therapies specifically targeting Chronic Obstructive Pulmonary Disease (COPD). The company's pipeline focuses on combination drug products, including LABA/LAMA and LABA/LAMA/ICS formulations delivered via nebulization. This approach aims to provide improved treatment options for respiratory patients through advanced drug-device combination products.